MediPal Holdings Corporation
7459
Rank in Stocks
#4283
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Share Price
$20.40
Market Cap
$3.70B
Change (1 day)
0.42%
Change (1 year)
19.72%
Country
JP
Trade MediPal Holdings Corporation (7459)
Category
Healthcare
Revenue for MediPal Holdings Corporation (7459)
Revenue in Jun 2026 TTM: $25.20B
According to MediPal Holdings Corporation latest financial reports the company's current revenue (TTM) is $25.20B. In 2024 the company made a revenue of $23.51B a decrease compared to the revenue in the year 2023 that was $25.31B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MediPal Holdings Corporation from 2005 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $25.20B | 2.87% |
| 2025 | $24.49B | 4.17% |
| 2024 | $23.51B | -7.09% |
| 2023 | $25.31B | -6.37% |
| 2022 | $27.03B | -6.78% |
| 2021 | $28.99B | -4.18% |
| 2020 | $30.26B | 5.55% |
| 2019 | $28.67B | -3.20% |
| 2018 | $29.61B | 7.65% |
| 2017 | $27.51B | 2.21% |
| 2016 | $26.91B | 12.36% |
| 2015 | $23.95B | -16.19% |
| 2014 | $28.58B | -4.19% |
| 2013 | $29.83B | -10.02% |
| 2012 | $33.15B | 3.19% |
| 2011 | $32.13B | 17.91% |
| 2010 | $27.25B | 8.82% |
| 2009 | $25.04B | 10.72% |
| 2008 | $22.61B | 23.12% |
| 2007 | $18.37B | 12.44% |
| 2006 | $16.34B | 4.97% |
| 2005 | $15.56B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $410.98B | 1,531.20% |
US
|
|
| - | - |
US
|
|
| $254.25B | 909.11% |
US
|
|
| - | - |
US
|
|
| $7.64B | -69.67% |
AU
|
